Form 4: Septerna Inc. CFO Gil M Labrucherie Reports Stock Option Grant
SEC Form 4 Filing
Gil M Labrucherie, CFO of Septerna Inc., reports the acquisition of stock options.
Summary
- This is a Form 4 filing indicating a change in beneficial ownership for Gil M Labrucherie, the Chief Financial Officer of Septerna, Inc.
- On February 7, 2025, Labrucherie acquired stock options for 222,000 shares of Septerna's common stock at an exercise price of $13.09.
- These options vest over time, with 25% vesting on January 6, 2026, and the remaining 75% vesting in equal monthly installments over the following 36 months, contingent upon continued service to the company.
- The options expire on February 6, 2035.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders.
Positives
- The granting of stock options to the CFO aligns his interests with those of the shareholders, incentivizing him to work towards increasing the company's value.
- The vesting schedule encourages long-term commitment from the CFO.
Industry Context
Stock options are a common form of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with those of shareholders.
Comparison to Industry Standards
- Stock option grants are a standard component of compensation packages for executives in publicly traded companies, particularly in the biotech sector.
- Vesting schedules, such as the one described in the filing, are typical and designed to incentivize long-term commitment.
- The size of the grant (222,000 shares) would need to be compared to grants made to CFOs at comparable companies to determine if it is within industry norms.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the CFO to increase company value.
- The CFO is incentivized to remain with the company and contribute to its long-term success.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date of transaction: Stock options acquired |
| 01/06/2026 | 25% of the stock options vest |
| 02/06/2035 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.